|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.58 USD | +2.77% |
|
+2.66% | +3.78% |
| 01-20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 01-20 | Rothschild & Co Redburn Adjusts Price Target on Gilead Sciences to $159 From $153, Maintains Buy Rating | MT |
Group Gilead Sciences, Inc.: Relations chart
Private companies belonging to the same group as GILEAD SCIENCES, INC.
| Company | Manager |
|---|---|
Gilead Sciences Ireland UC
 Gilead Sciences Ireland UC Engages in discover, develops and deliver innovative therapeutics for life-threatening diseases | - |
Gilead Therapeutics A1 Unlimited Co.
 Gilead Therapeutics A1 Unlimited Co. Develops and manufactures pharmaceutical medicines | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition